On April 2, the president unveiled his touted tariff and trade policy. It featured a sweeping 10% global tariff, along with higher "reciprocal tariffs" on dozens of countries that were deemed to have adverse trade imbalances with America.

Trump is expected to tell agencies to reclassify marijuana as a Schedule III drug, The Washington Post reported on Thursday. Such a move would allow cannabis companies to fall under different tax regulations and encourage investment, while placing pot in a class of drug that includes steroids and Tylenol with codeine.

An upcoming US Supreme Court ruling on the legality of the sweeping tariffs that President Donald Trump rolled out in April — briefly sending markets worldwide into a tailspin — could be the next test for stocks that have been flying high.

A senator is buying up shares of large financial company ahead of 2026. Here's a look at the recent trades from the close ally of President Donald Trump.

Tilray Brands stock price has rebounded in the past three days, and chances are that the surge will accelerate as a new catalyst emerges.

Newsom challenges Trump's economic agenda, saying it favors billionaires and leaves working families struggling. He proposes a billionaire tax.